{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:01:19Z","timestamp":1757624479460,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91904","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:27:08Z","timestamp":1757424428000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Transition From Covert, Involuntary Oral Medication to Consensual, Long-Acting, Injectable Antipsychotic Therapy in a Patient With Schizophrenia: A Case Report From Japan"],"prefix":"10.7759","author":[{"given":"Yoshiyo","family":"Oguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumi","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","unstructured":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019. a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022, 9:137-50. 10.1016\/S2215-0366(21)00395-3","journal-title":"Lancet Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016","volume":"44","author":"Charlson FJ","year":"2018","unstructured":"Charlson FJ, Ferrari AJ, Santomauro DF, et al.. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophr Bull. 2018, 44:1195-203. 10.1093\/schbul\/sby058","journal-title":"Schizophr Bull"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00713-9","article-title":"Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis","volume":"34","author":"Yaegashi H","year":"2020","unstructured":"Yaegashi H, Kirino S, Remington G, Misawa F, Takeuchi H. Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis. CNS Drugs. 2020, 34:579-98. 10.1007\/s40263-020-00713-9","journal-title":"CNS Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/00207640211065675","article-title":"Study on covert administration of medications practices among persons with severe mental illness: a cross-sectional study","volume":"69","author":"Hegde PR","year":"2023","unstructured":"Hegde PR, Gowda GS, Vajawat B, Basavaraju V, Moirangthem S, Naveen Kumar C, Bada Math S. Study on covert administration of medications practices among persons with severe mental illness: a cross-sectional study. Int J Soc Psychiatry. 2023, 69:28-37. 10.1177\/00207640211065675","journal-title":"Int J Soc Psychiatry"},{"key":"ref5","article-title":"","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. WHO Resource Book on Mental Health, Human Rights and Legislation. WHO Press, Geneva; 2005. https:\/\/books.google.co.in\/books\/about\/WHO_Resource_Book_on_Mental_Health_Human.html?id=616HbUCHKyMC&redir_esc=y."},{"key":"ref6","article-title":"A literature review on the current status and ethical issues of covert medication in psychiatric care","volume":"20","author":"Kimura S","year":"2019","unstructured":"Kimura S. A literature review on the current status and ethical issues of covert medication in psychiatric care. Otemae University Journal. 2019, 20:213-23.","journal-title":"Otemae University Journal"},{"key":"ref7","article-title":"Hikikomori. Adolescence Without End","author":"Saito T","year":"2013","unstructured":"Saito T. Hikikomori. Adolescence Without End. University of Minnesota Press, Minneapolis; 2013."},{"key":"ref8","unstructured":"Cabinet Office, Government of Japan. Survey on the awareness and daily life of children and young people [In Japanese]. (2023). https.\/\/nsearch.cao.go.jp\/cao\/search.x?page=1&ie=utf8&ref=www.cao.go.jp&tmpl=ja&pid=PBU6Oe2EU2sGBZR1Ql4gYw..&qid=dcu_...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview","volume":"35","author":"Correll CU","year":"2021","unstructured":"Correll CU, Kim E, Sliwa JK, et al.. Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview. CNS Drugs. 2021, 35:39-59. 10.1007\/s40263-020-00779-5","journal-title":"CNS Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12435","article-title":"Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey","volume":"44","author":"Oguchi Y","year":"2024","unstructured":"Oguchi Y, Miyake N, Ando K. Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey. Neuropsychopharmacol Rep. 2024, 44:417-23. 10.1002\/npr2.12435","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.06.005","article-title":"A preliminary examination of the validity and reliability of a\u00a0new\u00a0brief\u00a0rating scale for symptom domains of psychosis: Brief\u00a0Evaluation of Psychosis Symptom Domains (BE-PSD)","volume":"80","author":"Takeuchi H","year":"2016","unstructured":"Takeuchi H, Fervaha G, Lee J, Agid O, Remington G. A preliminary examination of the validity and reliability of a\u00a0new\u00a0brief\u00a0rating scale for symptom domains of psychosis: Brief\u00a0Evaluation of Psychosis Symptom Domains (BE-PSD). J Psychiatr Res. 2016, 80:87-92. 10.1016\/j.jpsychires.2016.06.005","journal-title":"J Psychiatr Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20220804-02","article-title":"Determinants of burden in family caregivers of individuals with schizophrenia: a systematic review","volume":"61","author":"Sustrami D","year":"2023","unstructured":"Sustrami D, Yusuf A, Fitryasari R, Suhardiningsih AV, Arifin H. Determinants of burden in family caregivers of individuals with schizophrenia: a systematic review. J Psychosoc Nurs Ment Health Serv. 2023, 61:38-43. 10.3928\/02793695-20220804-02","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.156.6.798","article-title":"Insight and psychosis","volume":"156","author":"David AS","year":"1990","unstructured":"David AS. Insight and psychosis. Br J Psychiatry. 1990, 156:798-808. 10.1192\/bjp.156.6.798","journal-title":"Br J Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20084","article-title":"Uses and abuses of recovery: implementing recovery-oriented practices in mental health systems","volume":"13","author":"Slade M","year":"2014","unstructured":"Slade M, Amering M, Farkas M, et al.. Uses and abuses of recovery: implementing recovery-oriented practices in mental health systems. World Psychiatry. 2014, 13:12-20. 10.1002\/wps.20084","journal-title":"World Psychiatry"},{"key":"ref15","article-title":"Policy making for recovery from schizophrenia","volume":"64","author":"Fujii C","year":"2018","unstructured":"Fujii C. Policy making for recovery from schizophrenia. Journal of Mental Health. 2018, 64:15-20.","journal-title":"Journal of Mental Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S150568","article-title":"Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia","volume":"13","author":"Brasso C","year":"2017","unstructured":"Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P. Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia. Neuropsychiatr Dis Treat. 2017, 13:2767-79. 10.2147\/NDT.S150568","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: guideline for pharmacological therapy of schizophrenia","volume":"41","author":"Japanese Society of Neuropsychopharmacology","year":"2021","unstructured":"Japanese Society of Neuropsychopharmacology. Japanese Society of Neuropsychopharmacology: guideline for pharmacological therapy of schizophrenia. Neuropsychopharmacol Rep. 2021, 41:266-324.","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20167","article-title":"The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia","volume":"13","author":"Galderisi S","year":"2014","unstructured":"Galderisi S, Rossi A, Rocca P, et al.. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014, 13:275-87. 10.1002\/wps.20167","journal-title":"World Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a006960","article-title":"At issue: management of medication noncompliance in schizophrenia by families in India","volume":"28","author":"Srinivasan TN","year":"2002","unstructured":"Srinivasan TN, Thara R. At issue: management of medication noncompliance in schizophrenia by families in India. Schizophr Bull. 2002, 28:531-5. 10.1093\/oxfordjournals.schbul.a006960","journal-title":"Schizophr Bull"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto T","year":"2021","unstructured":"Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies. Lancet Psychiatry. 2021, 8:387-404. 10.1016\/S2215-0366(21)00039-0","journal-title":"Lancet Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398332-successful-transition-from-covert-involuntary-oral-medication-to-consensual-long-acting-injectable-antipsychotic-therapy-in-a-patient-with-schizophrenia-a-case-report-from-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:27:09Z","timestamp":1757424429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398332-successful-transition-from-covert-involuntary-oral-medication-to-consensual-long-acting-injectable-antipsychotic-therapy-in-a-patient-with-schizophrenia-a-case-report-from-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.91904","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}